Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Biofrontera Inc WT (BFRIW)

Biofrontera Inc WT (BFRIW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Biofrontera Inc. Closes a $4.2 Million Senior Secured Convertible Note GlobeNewswire - Fri Nov 22, 8:10AM CST

BFRI : 0.8700 (+14.62%)
BFRIW : 0.0639 (-1.69%)
Biofrontera Inc. Reports Third Quarter and Nine-Month 2024 Financial Results and Provides Business Update GlobeNewswire - Wed Nov 13, 4:15PM CST

BFRI : 0.8700 (+14.62%)
BFRIW : 0.0639 (-1.69%)
Biofrontera Inc. Announces Highly Significant Results In Phase 3 Study Of Ameluz®-Photodynamic Therapy (PDT) Regarding The Treatment Of Superficial Basal Cell Carcinoma (sBCC) GlobeNewswire - Thu Oct 31, 9:32AM CDT

BFRI : 0.8700 (+14.62%)
BFRIW : 0.0639 (-1.69%)
Biofrontera Inc. Announces Database Lock Of Phase 3 Study Of Ameluz®-Photodynamic Therapy (PDT) In The Treatment Of Superficial Basal Cell Carcinoma (sBCC) GlobeNewswire - Mon Oct 14, 9:30AM CDT

BFRI : 0.8700 (+14.62%)
BFRIW : 0.0639 (-1.69%)
FDA Approves Use of Up To Three Tubes of Biofrontera Inc.’s Ameluz (aminolevulinic acid HCI) Topical Gel, 10% In One Treatment GlobeNewswire - Mon Oct 7, 7:45AM CDT

BFRI : 0.8700 (+14.62%)
BFRIW : 0.0639 (-1.69%)
Biofrontera Inc. Announces Patent in Australia for Novel Illumination Protocols Granted to Biofrontera Bioscience GmbH Globe Newswire - Mon Aug 1, 2022

Patent Improves Differentiated Profile of Ameluz-PDT by Expected Reduced Pain Intensity while Maintaining Efficacy WOBURN, Mass., Aug. 01, 2022 (GLOBE...

BFRI : 0.8700 (+14.62%)
BFRIW : 0.0639 (-1.69%)
Biofrontera Inc. Announces Exercise of Existing Warrants and Issuance of Warrants in Private Placement Globe Newswire - Wed Jul 27, 2022

WOBURN, Mass., July 27, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of...

BFRIW : 0.0639 (-1.69%)
BFRI : 0.8700 (+14.62%)
Biofrontera, Inc. Recognized for Rapid Sales Growth, Innovative Therapies and Marketing Excellence Globe Newswire - Thu Jun 9, 2022

Named Among the 10 Fastest-Growing Life Sciences Companies to Watch in 2022 by CIOCoverage Magazine New Ameluz® Marketing Campaign Receives Gold 2022...

BFRI : 0.8700 (+14.62%)
BFRIW : 0.0639 (-1.69%)
Biofrontera Inc. to Participate in The Benchmark Healthcare House Call Virtual 1x1 Conference Globe Newswire - Tue May 31, 2022

WOBURN, Mass., May 31, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of...

BFRIW : 0.0639 (-1.69%)
BFRI : 0.8700 (+14.62%)
New Data and Forecasts for the U.S. Skin Cancer Market Strongly Support the Commercial Opportunity for Biofrontera’s Ameluz® Globe Newswire - Tue May 24, 2022

WOBURN, Mass., May 24, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of...

BFRIW : 0.0639 (-1.69%)
BFRI : 0.8700 (+14.62%)

Barchart Exclusives

3 High-Yielding Dividend Kings to Boost Your Income in 2025 and Beyond Barchart - Fri Nov 22, 6:00PM CST
These three high-quality companies are currently on sale, offering elevated yields that appeal to dividend growth investors. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot